In the News

CFIUS’s Genetic Data Criteria Could Ensnare More Biotech Investments, BioCentury

September 20, 2019

Morgan Lewis partner Stephen Mahinka was interviewed by BioCentury for an article about new regulations proposed by the US Treasury that would expand the scope of the Committee on Foreign Investment in the United States (CFIUS) regarding investments in “critical technology” areas such as the life sciences and medical technology sectors.

Read the full BioCentury article >>